Anthropic acquired Mithril, a one-person startup, and launched a pharmaceutical division.
The startup was developing drugs for two rare forms of muscular dystrophy. Its founder, using Claude, coordinated 11 external laboratories and, in less than 18 months, brought one candidate to promising results in mice.
He is now continuing the work at Anthropic.
